A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Despiperazine Bosutinib (USP) | CAS 2095306-25-3 - Request Quote

Picture of Despiperazine Bosutinib (USP)

A potential ICH M7 Class 4 compound

ICH M7

Despiperazine Bosutinib (USP)

SZ CAT No:SZ-B063008
CAS No
2095306-25-3
Mol.F.
C21H19Cl2N3O3
Mol.Wt.
432.3
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

CHNS Ratio (%) :

Usage Note:

Despiperazine Bosutinib (USP) is chemically 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-propoxyquinoline-3-carbonitrile (as per USP). Despiperazine Bosutinib (USP) is supplied with detailed characterization data compliant with regulatory guideline. Despiperazine Bosutinib (USP) can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bosutinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2095306-25-3

Purchase 2095306-25-3

Order 2095306-25-3

Enquire 2095306-25-3

price of 2095306-25-3

2095306-25-3 Supplier

2095306-25-3 Manufacturer

2095306-25-3 Exporter

buy high quality Despiperazine Bosutinib (USP)

Purchase Despiperazine Bosutinib (USP)

Despiperazine Bosutinib (USP) suppliers

Despiperazine Bosutinib (USP) manufacturers

Despiperazine Bosutinib (USP) price

Order Despiperazine Bosutinib (USP)

Enquire Despiperazine Bosutinib (USP)

Despiperazine Bosutinib (USP) cost

Despiperazine Bosutinib (USP) Supplier

Despiperazine Bosutinib (USP) Distributor

Despiperazine Bosutinib (USP) for Method Validation

Bosutinib Reference Standard

Despiperazine Bosutinib (USP) for ANDA Filing

Despiperazine Bosutinib (USP) for Forced Degradation Studies

Despiperazine Bosutinib (USP) Identification Standards

Despiperazine Bosutinib (USP) for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.